Fang Cheng

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Chronic Myeloid Leukemia

Oxide Nanoparticles

Bioinformatics Analysis

Ejection Fraction

Top Venues

Disease markers

Journal of immunology research

Journal of clinical pharmacy and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Fang Cheng, Qiang Li, Zheng Cui, Zhendi Wang, Fang Zeng, Yu Zhang
Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection. Journal of immunology research 2022 (2022)
Fang Cheng, Qiang Li, Jinglin Wang, Liu Wang, Wei-Ming Li, Fang Zeng
HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia. Disease markers 2022 (2022)
Fang Cheng, Fang Zeng, Qiang Li, Zheng Cui, Yilin Chen, Wei-Ming Li, Yu Zhang
Imatinib dose optimization based on therapeutic drug monitoring in Chinese patients with chronic-phase chronic myeloid leukemia. Cancer 128 (22) (2022)
Fang Cheng, Fang Zeng, Qiang Li, Zheng Cui, Yilin Chen, Wei-Ming Li, Yu Zhang
Reply to "Plasma imatinib trough levels for predicting efficacy and toxicity in patients with chronic myeloid leukemia in chronic phase: Still a matter of debate!" Cancer (2022)
Fang Cheng, Qiang Li, Jinglin Wang, Fang Zeng, Yu Zhang
Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients. Journal of clinical pharmacy and therapeutics 46 (6) (2021)
Fang Cheng, Qiang Li, Jinglin Wang, Fang Zeng, Kaiping Wang, Yu Zhang
Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis. Disease markers 2020 (2020)